By Sindhu Sundar ( February 17, 2012, 7:00 PM EST) -- A European regulator warned on Friday that Novartis AG's blood pressure drug Rasilez should not be prescribed to certain patients with Type 1 or Type 2 diabetes or kidney problems, and called for warnings to be included in the labeling of such medications in the European Union....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.